DHMMF also inhibits lipid synthesis in the human HCC cells by modulating the functions of SREBP1 and its downstream proteins ACC, FASN and SCD1, which contributes to its anti‐HCC effects. The gene discussed is FASN; the disease is hepatocellular carcinoma.